August 21, 2017 / 12:26 PM / in 4 months

BRIEF-Cardiome provides U.S. regulatory update for BRINAVESS

Aug 21 (Reuters) - Cardiome Pharma Corp

* Cardiome provides U.S. regulatory update for BRINAVESS

* Cardiome Pharma Corp - ‍FDA advised Cardiome that data package proposed by Cardiome would not be sufficient to support a resubmission of BRINAVESS NDA​

* Cardiome Pharma Corp - ‍Intends to explore every reasonable avenue available to make Vernakalant available in United States​

* Cardiome Pharma Corp - ‍“We will continue to have a dialogue with FDA as we review our regulatory options” for BRINAVESS​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below